These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 31237944)

  • 21. Interplay between α-synuclein and parkin genes: Insights of Parkinson's disease.
    Sharma K; Chib S; Gupta A; Singh R; Chalotra R
    Mol Biol Rep; 2024 Apr; 51(1):586. PubMed ID: 38683365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between Parkin and
    Madsen DA; Schmidt SI; Blaabjerg M; Meyer M
    Cells; 2021 Jan; 10(2):. PubMed ID: 33572534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of parkin in Parkinson's disease].
    Miklya I; Göltl P; Hafenscher F; Pencz N
    Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival.
    Lee Y; Stevens DA; Kang SU; Jiang H; Lee YI; Ko HS; Scarffe LA; Umanah GE; Kang H; Ham S; Kam TI; Allen K; Brahmachari S; Kim JW; Neifert S; Yun SP; Fiesel FC; Springer W; Dawson VL; Shin JH; Dawson TM
    Cell Rep; 2017 Jan; 18(4):918-932. PubMed ID: 28122242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration.
    Stevens DA; Lee Y; Kang HC; Lee BD; Lee YI; Bower A; Jiang H; Kang SU; Andrabi SA; Dawson VL; Shin JH; Dawson TM
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11696-701. PubMed ID: 26324925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T α-synuclein model of Parkinson's disease.
    Chen J; Ren Y; Gui C; Zhao M; Wu X; Mao K; Li W; Zou F
    Cell Death Dis; 2018 Jun; 9(6):700. PubMed ID: 29899409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
    Corti O; Brice A
    Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Part I: parkin-associated proteins and Parkinson's disease.
    Dev KK; van der Putten H; Sommer B; Rovelli G
    Neuropharmacology; 2003 Jul; 45(1):1-13. PubMed ID: 12814656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
    Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
    Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkin and alpha-synuclein: opponent actions in the pathogenesis of Parkinson's disease.
    Baptista MJ; Cookson MR; Miller DW
    Neuroscientist; 2004 Feb; 10(1):63-72. PubMed ID: 14987449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interplay between parkin and alpha-synuclein; possible implications for the pathogenesis of Parkinson's disease.
    Jęśko H; Lenkiewicz AM; Wilkaniec A; Adamczyk A
    Acta Neurobiol Exp (Wars); 2019; 79(3):276-289. PubMed ID: 31587020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of parkin promotes lipid rafts-dependent endocytosis through accumulating caveolin-1: implications for Parkinson's disease.
    Cha SH; Choi YR; Heo CH; Kang SJ; Joe EH; Jou I; Kim HM; Park SM
    Mol Neurodegener; 2015 Dec; 10():63. PubMed ID: 26627850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease.
    Romaní-Aumedes J; Canal M; Martín-Flores N; Sun X; Pérez-Fernández V; Wewering S; Fernández-Santiago R; Ezquerra M; Pont-Sunyer C; Lafuente A; Alberch J; Luebbert H; Tolosa E; Levy OA; Greene LA; Malagelada C
    Cell Death Dis; 2014 Aug; 5(8):e1364. PubMed ID: 25101677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular chaperones and Parkinson's disease.
    Hu S; Tan J; Qin L; Lv L; Yan W; Zhang H; Tang B; Wang C
    Neurobiol Dis; 2021 Dec; 160():105527. PubMed ID: 34626793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells.
    Machida Y; Chiba T; Takayanagi A; Tanaka Y; Asanuma M; Ogawa N; Koyama A; Iwatsubo T; Ito S; Jansen PH; Shimizu N; Tanaka K; Mizuno Y; Hattori N
    Biochem Biophys Res Commun; 2005 Jun; 332(1):233-40. PubMed ID: 15896322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkin deficiency delays motor decline and disease manifestation in a mouse model of synucleinopathy.
    Fournier M; Vitte J; Garrigue J; Langui D; Dullin JP; Saurini F; Hanoun N; Perez-Diaz F; Cornilleau F; Joubert C; Ardila-Osorio H; Traver S; Duchateau R; Goujet-Zalc C; Paleologou K; Lashuel HA; Haass C; Duyckaerts C; Cohen-Salmon C; Kahle PJ; Hamon M; Brice A; Corti O
    PLoS One; 2009 Aug; 4(8):e6629. PubMed ID: 19680561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. alpha-Synuclein aggregates interfere with Parkin solubility and distribution: role in the pathogenesis of Parkinson disease.
    Kawahara K; Hashimoto M; Bar-On P; Ho GJ; Crews L; Mizuno H; Rockenstein E; Imam SZ; Masliah E
    J Biol Chem; 2008 Mar; 283(11):6979-87. PubMed ID: 18195004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repression of rRNA transcription by PARIS contributes to Parkinson's disease.
    Kang H; Shin JH
    Neurobiol Dis; 2015 Jan; 73():220-8. PubMed ID: 25315684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson's disease.
    Imam SZ; Zhou Q; Yamamoto A; Valente AJ; Ali SF; Bains M; Roberts JL; Kahle PJ; Clark RA; Li S
    J Neurosci; 2011 Jan; 31(1):157-63. PubMed ID: 21209200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration.
    Corti O; Hampe C; Koutnikova H; Darios F; Jacquier S; Prigent A; Robinson JC; Pradier L; Ruberg M; Mirande M; Hirsch E; Rooney T; Fournier A; Brice A
    Hum Mol Genet; 2003 Jun; 12(12):1427-37. PubMed ID: 12783850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.